{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T03:53:31Z","timestamp":1795146811599,"version":"4.10.3"},"reference-count":21,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2010,2,26]],"date-time":"2010-02-26T00:00:00Z","timestamp":1267142400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Clinical Exper Ophthalmology"],"published-print":{"date-parts":[[2010,5]]},"abstract":"<jats:title>\n                    A\n                    <jats:sc>bstract<\/jats:sc>\n                  <\/jats:title>\n                  <jats:p>\n                    <jats:bold>Background:\u2002<\/jats:bold>\n                    To compare the effects of different doses of bevacizumab with both saline and dexamethasone on inflammatory angiogenesis in the rat cornea induced by small chemical lesions.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Methods:\u2002<\/jats:bold>\n                    Corneal chemical cauterization was performed on 24 rats. Animals were divided randomly into six groups and received a daily subconjunctival injection for 7\u2003days of: balanced salt solution 0.1\u2003mL or dexamethasone phosphate 4\u2003mg\/day or bevacizumab 2.5\u2003mg\/day, 3.75\u2003mg\/day, 5.0\u2003mg\/day or bevacizumab 5.0\u2003mg\/day\u2003+\u2003dexamethasone phosphate 4\u2003mg\/day. Clinical examination under slit lamp was performed daily for 7\u2003days to evaluate corneal opacity and vessel size evolution. Computer\u2010assisted quantitative image analysis was used to measure the total corneal area covered by neovascularization.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Results:\u2002<\/jats:bold>\n                    At final examination, the dexamethasone, bevacizumab 5.0\u2003mg\/day and dexamethasone\u2003+\u2003bevacizumab groups showed a significant lowering in corneal opacity score as compared with control (\n                    <jats:italic>P<\/jats:italic>\n                    \u2003=\u20030.024,\n                    <jats:italic>P<\/jats:italic>\n                    \u2003=\u20030.006 and\n                    <jats:italic>P<\/jats:italic>\n                    \u2003=\u20030.013, respectively). Also, a significant reduction on new vessels size score was observed. Surface of corneal neovascularization was significantly reduced in dexamethasone, bevacizumab 5.0\u2003mg\/day and dexamethasone\u2003+\u2003bevacizumab groups compared with control (\n                    <jats:italic>P<\/jats:italic>\n                    \u2003=\u20030.045,\n                    <jats:italic>P<\/jats:italic>\n                    \u2003=\u20030.047 and\n                    <jats:italic>P<\/jats:italic>\n                    \u2003=\u20030.044, respectively).\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Conclusion:\u2002<\/jats:bold>\n                    Our study demonstrates the ability of a 5.0\u2003mg\/day bevacizumab subconjunctival injection, in monotherapy or associated with dexamethasone, to cause a short\u2010term involution of corneal neovascularization after corneal alkali burn. Combination of both of these treatments may have advantages to monotherapy approaches.\n                  <\/jats:p>","DOI":"10.1111\/j.1442-9071.2010.02252.x","type":"journal-article","created":{"date-parts":[[2010,2,26]],"date-time":"2010-02-26T05:25:23Z","timestamp":1267161923000},"page":"346-352","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["Inhibition of corneal neovascularization after alkali burn: comparison of different doses of bevacizumab in monotherapy or associated with dexamethasone"],"prefix":"10.1111","volume":"38","author":[{"given":"Louis","family":"Hoffart","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederic","family":"Matonti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Conrath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Daniel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Ridings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume S","family":"Masson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederic","family":"Chavane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2010,6,11]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1097\/00055735-200108000-00002"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0420.2002.800102.x"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0420.2004.00229.x"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1006\/exer.2002.2075"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI20465"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.03-0940"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.2416056"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1007\/s004170050387"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1006\/exer.1998.0512"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.91.9.4082"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1442-9071.2007.01572.x"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1590\/S0001-37652007000300004"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.2006.107912"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0420.2007.01049.x"},{"key":"e_1_2_6_16_2","unstructured":"H\u00f6fling\u2010LimaA BelfortR Jr FreitasD FarahM.Intrastromal injection of Bevacizumab (Avastin) for treatment of corneal neovascularization. American Academy of Ophthalmology Annual Meeting; November 11\u201314 2006 Las Vegas 2006."},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.07-1175"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.06-0570"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.ico.0000220768.11778.60"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.ico.0000178731.42187.46"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1994.01090180111045"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1038\/eye.1990.86"}],"container-title":["Clinical &amp; Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1442-9071.2010.02252.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1442-9071.2010.02252.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T19:51:34Z","timestamp":1697399494000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1442-9071.2010.02252.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5]]},"references-count":21,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,5]]}},"alternative-id":["10.1111\/j.1442-9071.2010.02252.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1442-9071.2010.02252.x","archive":["Portico"],"relation":{},"ISSN":["1442-6404","1442-9071"],"issn-type":[{"value":"1442-6404","type":"print"},{"value":"1442-9071","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,5]]},"assertion":[{"value":"2010-06-11","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}